Total-Body PET and Long Axial FOV Scanners

Total-body and long axial field-of-view (LAFOV) PET scanners image 106 cm to 194 cm of the patient in a single bed position instead of the roughly 15-26 cm of a conventional scanner, and that geometry raises coincidence sensitivity by about a factor of 40 for total-body imaging. That sensitivity is a currency: a facility can spend it on faster scans, lower injected activity, delayed low-count imaging, or whole-body dynamic kinetic modeling. Realizing it safely and quantitatively depends on NEMA-based acceptance testing and careful calibration across the entire field.¹²³

This is arguably the largest change in PET instrumentation since the modality entered mainstream clinical use, and it changes what a medical physicist must verify at acceptance and maintain in quality control. This guide explains where the sensitivity gain comes from, the measured performance of the two flagship systems, a worked dose-and-time calculation, the clinical applications the technology unlocks, and the testing and regulatory considerations that keep quantification defensible.¹⁶

Introduction

For decades, a "whole-body" PET study has been a polite fiction. Conventional PET/CT scanners have an axial field of view (AFOV) of roughly 15 to 26 cm, so a study from the skull base to the thighs is assembled from six to eight overlapping bed positions, each imaged in sequence while the rest of the patient's activity goes unrecorded.¹³ At any instant, the scanner captures annihilation photons from only a short segment of the body and discards the vast majority of the emitted signal.

Total-body and LAFOV PET systems break that constraint. The uEXPLORER, the first commercial total-body PET/CT, extends the detector to about 194 cm — enough to image an entire adult at once — while the Biograph Vision Quadra reaches about 106 cm, covering the head-to-thigh region in a single position.²³ Capturing so much more of the emitted signal at once produces an order-of-magnitude gain in sensitivity, and that single physical change cascades into lower dose, faster scans, and entirely new imaging paradigms.¹⁶⁷

This article is written for facilities and radiation safety programs evaluating, acquiring, or already operating these systems. DRPS supports them through PET/CT and nuclear medicine physics and medical physicist consulting across Florida, Maryland, Virginia, Washington DC, California, Nevada, Pennsylvania, New York, New Jersey, and Delaware.

Topic Explanation

What "long axial field of view" actually means

A PET scanner detects positron annihilation by recording the two 511 keV photons that fly out in nearly opposite directions and strike two detectors within a short coincidence window. The line connecting those two detectors is a line of response (LOR), and the image is reconstructed from millions of LORs. In a conventional scanner, the detector is a relatively short ring, so only photon pairs whose LOR happens to fall within that short axial extent can be recorded. Every annihilation whose photons head toward detectors outside the ring is simply lost.¹

Lengthening the detector along the patient axis does two things at once. First, it captures a far larger fraction of the total emitted solid angle for any given point in the body. Second, it enables a huge number of new oblique LORs connecting detector rings that are far apart axially — LORs that do not exist at all in a short scanner. The combination is what drives the sensitivity gain; it is not merely a longer gantry but a fundamentally larger acceptance geometry.¹³⁷

The sensitivity gain

The seminal analysis of total-body PET estimated that extending coverage to the whole body increases sensitivity by roughly a factor of 40 for total-body imaging, and by about 4 to 5 for imaging a single organ such as the brain or heart, relative to a conventional system.¹ When combined with time-of-flight improvements, the effective sensitivity gain can be even larger.¹

That gain is confirmed by NEMA measurements on the delivered systems. It is the reason the technology is transformative rather than incremental: a 40-fold increase in recorded signal is an enormous reserve that can be converted into whatever a program values most — speed, dose reduction, delayed imaging, or dynamic data. For the emission characteristics of the tracers used, see our overview of common PET and radiopharmaceutical-therapy isotopes.

Key Technical Principles

The geometry of solid-angle coverage

The intuition behind the sensitivity gain is captured by the axial acceptance angle. For a point source at the center of a cylindrical detector of ring radius $R$ and axial length $L$ , the maximum half-angle over which coincident photon pairs can be accepted is approximately:

θ_{1/2} = arctan (\frac{L /2}{R})

Take an approximate ring radius $R \approx 40$ cm and compare three axial lengths. For a conventional scanner with $L = 20$ cm:

θ_{1/2} = arctan (\frac{10}{40}) = arctan (0.25) \approx 1 4^{\circ}

For a LAFOV system with $L = 106$ cm:

θ_{1/2} = arctan (\frac{53}{40}) = arctan (1.33) \approx 5 3^{\circ}

and for a total-body system with $L = 194$ cm:

θ_{1/2} = arctan (\frac{97}{40}) = arctan (2.43) \approx 6 8^{\circ}

The accepted angular range grows from about 14 degrees to roughly 68 degrees. Because the number of usable oblique LORs grows faster than linearly with axial length, the sensitivity gain is far larger than the ratio of the lengths alone — which is exactly why the measured gain approaches an order of magnitude or more.¹³ (These figures are illustrative geometry; the delivered gain is what NEMA testing quantifies.)

Converting sensitivity into dose or time

The practical payoff is governed by a simple relationship. The number of counts $N$ that build an image is the product of system sensitivity $S$ , injected activity $A$ , and scan time $T$ (holding tracer distribution and decay fixed for the comparison):

N = S \cdot A \cdot T

To hold image quality — and therefore count statistics — constant while sensitivity increases by a factor $g = S_{2} / S_{1}$ , the product of activity and time must fall by the same factor:

\frac{A _{2} T _{2}}{A _{1} T _{1}} = \frac{S _{1}}{S _{2}} = \frac{1}{g}

Worked example. Suppose a conventional $^{18}$ F-FDG protocol uses $A_{1} = 370$ MBq (10 mCi) and $T_{1} = 20$ min of PET acquisition, and a total-body system offers $g = 40$ . The facility can spend that budget in different ways:

Dose reduction, same scan time: $A_{2} = A_{1} / g = 370/40 \approx 9$ MBq (about 0.25 mCi).
Time reduction, same activity: $T_{2} = T_{1} / g = 20 min /40 = 0.5$ min (about 30 s).
A balanced split, for example halving both dose and time and keeping a comfortable statistical margin.

Real protocols rarely push the full factor of 40 into a single axis, because programs keep reserve for image quality, motion, and clinical robustness. But even conservative use of the gain yields substantially lower administered activity or dramatically shorter acquisitions than a conventional scanner — a genuinely different operating point.¹⁶⁷

Measured performance of the flagship systems

The NEMA NU 2 standard measures spatial resolution, sensitivity, count-rate performance (peak noise-equivalent count rate, NECR), scatter fraction, time-of-flight (TOF) resolution, and image quality, with additional tests devised to characterize the long AFOV.²³⁸ The published acceptance-style evaluations report:

Parameter	Conventional digital PET (≈20-26 cm)	Biograph Vision Quadra (106 cm)	uEXPLORER (194 cm)
Axial field of view	~15-26 cm	106 cm	194 cm
NEMA sensitivity	order of ~15-25 kcps/MBq	83 cps/kBq (MRD 85); 176 cps/kBq (MRD 322)	174 kcps/MBq
Spatial resolution (FWHM, near center)	~4 mm	3.3 / 3.4 / 3.8 mm (radial/tangential/axial)	≤ 3.0 mm
TOF resolution	~210-240 ps	228-230 ps	~430 ps class
Peak NECR	~300 kcps class	1,613 kcps (MRD 85); 2,956 kcps (MRD 322)	~2 Mcps (total-body geometry)

Values for the Quadra are from the NEMA NU 2-2018 evaluation by Prenosil and colleagues, and for the uEXPLORER from Spencer and colleagues; the conventional-scanner column is an approximate reference range for context.²³ Note that the Quadra's sensitivity and NECR nearly double when the maximum ring difference is opened from MRD 85 to MRD 322, directly illustrating how accepting more oblique LORs converts geometry into signal.³

Keeping quantification honest across a huge field

A larger field brings a quantification challenge: activity is now distributed across up to two meters of axial extent and a very wide dynamic range, and standardized uptake values (SUV) must be accurate wherever a lesion falls. The uEXPLORER quantitative-accuracy evaluation reported count-rate accuracy within about ±3-4% under the NEMA protocol and an axial uniformity spread of about ±3% across the central 90% of the AFOV — good, but only because it was measured and verified.⁴ The physicist's job is to confirm that calibration, normalization, scatter and randoms corrections, and axial uniformity hold across the whole field so that SUVs are trustworthy end to end.⁴⁵ This is a direct extension of the same discipline covered in our guides to PET SUV quantification and EARL PET SUV harmonization.

Clinical Impact

The sensitivity reserve translates into four broad categories of clinical and research value.⁶⁷

Faster scans and higher throughput. Total-body coverage can compress a multi-position acquisition into a single short scan, improving comfort for patients who struggle to hold still and increasing scanner capacity.⁶⁷
Lower administered activity. Reduced dose is especially valuable for pediatric patients, patients undergoing serial imaging, and research volunteers, and it eases logistics around tracer supply.⁶⁷
Delayed and low-count imaging. With so much sensitivity in reserve, useful images can be acquired many hours after injection or at very low count levels, extending the practical imaging window well beyond one or two half-lives.⁶⁷
Whole-body dynamic imaging and long-half-life tracers. For the first time, kinetic modeling can be performed simultaneously across every organ, and low-activity, long-half-life tracers such as zirconium-89-labeled antibodies become far more practical — opening applications in multisystem disease, immuno-PET, and whole-body radiopharmaceutical dosimetry.⁶⁷

These capabilities matter for a consulting radiation-safety and physics practice because each one changes the facility's dose profile, workflow, and quality-control needs. A program that drops injected activity tenfold, for example, changes both its patient dosimetry and its occupational-exposure picture in the hot lab and injection area.

Practical Optimization Tips

At acquisition and acceptance

Insist on full NEMA NU 2 acceptance testing, including the LAFOV-specific extensions, and reconcile the vendor's stated performance against your measured results before clinical use.²³⁸
Verify quantitative calibration and axial uniformity across the entire field, not just at the center, so SUVs are accurate wherever lesions appear.⁴
Decide, in writing, how you will spend the sensitivity — the balance of dose reduction versus scan-time reduction versus image-quality margin should be a deliberate, documented protocol choice, not an accident of vendor defaults.⁶⁷

In the ongoing program

Adapt the QC program to the geometry. Daily and periodic QC, normalization, and well-counter cross-calibration must account for the long field; do not assume a short-scanner QC template transfers unchanged.⁴⁸
Reassess radiation safety for lower-activity workflows. Lower injected activity changes patient dosimetry, uptake-room occupancy assumptions, and potentially shielding margins established for conventional activities. See our PET/CT shielding calculations guide.
Manage the data burden. LAFOV systems, especially in dynamic mode, generate very large datasets; storage and reconstruction capacity are part of the operational plan.⁶

Common pitfalls

Treating it as "just a longer scanner." The physics of oblique LOR acceptance, axial uniformity, and count-rate behavior differ meaningfully from short systems.³⁷
Assuming SUV comparability out of the box. Without harmonization and verified calibration, SUVs from a LAFOV system may not be directly comparable to prior conventional-scanner studies.⁴
Under-testing the field edges. Performance and uniformity near the axial extremes deserve explicit verification.²⁴

Regulatory Considerations

A total-body or LAFOV PET/CT sits under the same regulatory frameworks as any PET/CT — byproduct-material rules for the radiopharmaceuticals and state radiation-machine rules for the CT — plus the performance-testing and accreditation expectations specific to PET.⁸

NEMA NU 2 is the consensus performance standard used for acceptance and characterization. The evaluations cited here used NEMA NU 2-2018; the standard has since been revised as NEMA NU 2-2024, so a current acceptance-testing plan should reference the edition in force and the manufacturer's stated compliance.⁸
Medical use of the PET radiopharmaceuticals falls under 10 CFR Part 35 (or the equivalent Agreement State program), with dose limits set by 10 CFR Part 20. Of the states DRPS serves, Florida, Maryland, Virginia, California, Nevada, Pennsylvania, New York, and New Jersey are NRC Agreement States that license medical use under their own rules, while Washington DC and Delaware are regulated directly by the NRC.
Accreditation. PET/CT accreditation (for example, through the ACR PET/CT program) and the associated qualified-medical-physicist performance evaluation apply to LAFOV systems as they do to any PET/CT, and a physicist's acceptance report is typically expected before clinical operation.⁸

The practical point for a radiation-safety program is that the new operating point — often much lower injected activity — should be reflected in the facility's written directives, dosimetry assumptions, and quality-control records rather than inherited unchanged from a conventional-scanner era. For broader compliance context, see common radiation safety violations and how to avoid them.

Frequently Asked Questions (FAQs)

What is a total-body or long axial field-of-view PET scanner?

It is a PET/CT system whose detector rings extend far enough along the patient axis to image most or all of the body in a single bed position. Conventional PET scanners cover roughly 15 to 26 cm axially, so a whole-body study is stitched together from several overlapping bed positions. Long axial field-of-view systems such as the Biograph Vision Quadra cover about 106 cm, and total-body systems such as the uEXPLORER cover about 194 cm, imaging head to thigh or the entire body at once.

Why are total-body PET scanners so much more sensitive?

Coincidence sensitivity depends on how much of the emitted annihilation-photon solid angle the detector captures. Extending the detector along the patient axis dramatically increases the fraction of coincident photon pairs that are recorded, and it also allows many more oblique lines of response between distant detector rings. The result is roughly a 40-fold gain in sensitivity for total-body imaging compared with a conventional scanner, and about a 4 to 5-fold gain for a single organ.

How can total-body PET reduce radiation dose?

Image quality in PET depends on the total number of counts collected, which is the product of sensitivity, injected activity, and scan time. If sensitivity increases by a large factor, a facility can hold image quality constant while reducing injected activity, shortening scan time, or a combination of the two. In practice this can mean substantially lower administered activity than a conventional protocol, or a full study in a fraction of the time.

What new applications does total-body PET enable?

The step change in sensitivity enables whole-body dynamic imaging and kinetic modeling of every organ simultaneously, delayed imaging many hours after injection, ultra-low-dose studies, imaging with long-half-life tracers such as zirconium-89 labeled antibodies, and improved image quality for pediatric and hard-to-image patients. It also supports research in multisystem disease and whole-body radiopharmaceutical dosimetry.

Does a long axial field-of-view PET scanner still need NEMA performance testing?

Yes. Acceptance and performance testing follow the NEMA NU 2 standard for sensitivity, spatial resolution, count-rate performance, scatter fraction, time-of-flight resolution, and image quality, with additional measurements devised specifically to characterize the long axial field of view. A qualified medical physicist performs acceptance testing, verifies quantitative calibration, and establishes the ongoing quality-control program.

Is SUV quantification reliable across the long axial field of view?

It can be, but it must be verified. Published evaluations of the uEXPLORER showed axial uniformity within a few percent across the central 90 percent of the field of view and count-rate accuracy within a few percent under NEMA conditions. Because activity is distributed across a very large axial extent and a wide dynamic range, the physicist must confirm calibration, corrections, and axial uniformity so that standardized uptake values are accurate wherever the lesion falls in the field.

Key Takeaways

Coverage drives everything. Extending the AFOV from ~20 cm to 106-194 cm captures far more of the emitted signal and enables new oblique LORs, raising sensitivity by about 40-fold for total-body imaging.¹²³
Sensitivity is a currency. The gain can be spent on faster scans, lower injected activity, delayed imaging, or whole-body dynamics — a deliberate, documented protocol choice.⁶⁷
The measured numbers are striking. The Quadra reports 176 cps/kBq at MRD 322 and the uEXPLORER 174 kcps/MBq, with sub-3 to 3.8 mm spatial resolution.²³
Quantification must be verified across the whole field. Axial uniformity and calibration were shown to hold within a few percent on the uEXPLORER — because they were measured.⁴
Testing and accreditation still apply. NEMA NU 2 acceptance (now the 2024 edition), a physicist performance evaluation, and PET/CT accreditation remain required.⁸
Radiation safety assumptions should be refreshed whenever a program moves to substantially lower injected activity.⁶⁷

Conclusion

Total-body and long axial field-of-view PET is the rare instrumentation change that alters not just image quality but the entire operating logic of a PET service. By capturing an order of magnitude more of the emitted signal, these systems hand the facility a large sensitivity reserve that can become lower dose, faster throughput, delayed and low-count imaging, or whole-body kinetic data. The engineering is remarkable, but the value is only realized if the physics is verified: full NEMA acceptance testing across the long field, confirmed quantitative calibration and axial uniformity, a QC program adapted to the geometry, and radiation-safety assumptions updated for the new activity levels. Handled that way, total-body PET is not just a longer gantry — it is a new and defensible standard of practice.

How DRPS Can Help

Diagnostic Radiation Physics Services supports PET/CT and nuclear medicine facilities evaluating or operating long axial field-of-view systems with PET/CT and nuclear medicine physics, NEMA-based acceptance testing, quantitative calibration and SUV verification, quality-control program development, updated shielding and radiation-safety review, and accreditation support — all delivered by board-certified medical physicists across our service locations, including Florida, Maryland, Virginia, Washington DC, California, Nevada, Pennsylvania, New York, New Jersey, and Delaware.

A new scanner is only as good as the testing behind it. We help facilities prove — and keep proving — that the performance and quantification are real.

Related Resources

References

Cherry SR, Jones T, Karp JS, Qi J, Moses WW, Badawi RD. Total-Body PET: Maximizing Sensitivity to Create New Opportunities for Clinical Research and Patient Care. J Nucl Med. 2018;59(1):3-12. doi:10.2967/jnumed.116.184028. PubMed
Spencer BA, Berg E, Schmall JP, et al. Performance Evaluation of the uEXPLORER Total-Body PET/CT Scanner Based on NEMA NU 2-2018 with Additional Tests to Characterize PET Scanners with a Long Axial Field of View. J Nucl Med. 2021;62(6):861-870. doi:10.2967/jnumed.120.250597. PubMed
Prenosil GA, Sari H, Fürstner M, et al. Performance Characteristics of the Biograph Vision Quadra PET/CT System with a Long Axial Field of View Using the NEMA NU 2-2018 Standard. J Nucl Med. 2022;63(3):476-484. doi:10.2967/jnumed.121.261972. PubMed
Leung EK, Berg E, Omidvari N, et al. Quantitative accuracy in total-body imaging using the uEXPLORER PET/CT scanner. Phys Med Biol. 2021;66(20):205008. doi:10.1088/1361-6560/ac287c. PubMed
Leung EK, Abdelhafez YG, Berg E, et al. Relating $^{18}$F-FDG image signal-to-noise ratio to time-of-flight noise-equivalent count rate in total-body PET using the uEXPLORER scanner. Phys Med Biol. 2022;67(12):125009. doi:10.1088/1361-6560/ac72f1. PubMed
Cook GJR, Alberts IL, Wagner T, et al. The impact of long axial field of view (LAFOV) PET on oncologic imaging. Eur J Radiol. 2024;183:111873. doi:10.1016/j.ejrad.2024.111873. PubMed
Nardo L, Pantel AR. Oncologic Applications of Long Axial Field-of-View PET/Computed Tomography. PET Clin. 2021;16(1):65-73. doi:10.1016/j.cpet.2020.09.010. PubMed
National Electrical Manufacturers Association. NEMA NU 2: Performance Measurements of Positron Emission Tomographs (PET) (NU 2-2018; revised as NU 2-2024). Rosslyn, VA: NEMA. nema.org
United Imaging Healthcare. uEXPLORER Total-Body PET/CT — technical specifications. united-imaging.com
Siemens Healthineers. Biograph Vision Quadra PET/CT — technical specifications. siemens-healthineers.com
Society of Nuclear Medicine and Molecular Imaging. Total-body and long axial field-of-view PET resources. Reston, VA: SNMMI. snmmi.org